Infectious Diseases in Obstetrics and Gynecology

Infectious Diseases in Obstetrics and Gynecology / 2004 / Article

Open Access

Volume 12 |Article ID 650706 | https://doi.org/10.1080/10647440400003873

Per-Anders Mårdh, Jolanta Wågström, Maria Landgren, Jan Holmén, "Usage of Antifungal Drugs for Therapy of Genital Candida Infections, Purchased as Over-the-Counter Products or by Prescription: 1. Analyses of a Unique Database", Infectious Diseases in Obstetrics and Gynecology, vol. 12, Article ID 650706, 7 pages, 2004. https://doi.org/10.1080/10647440400003873

Usage of Antifungal Drugs for Therapy of Genital Candida Infections, Purchased as Over-the-Counter Products or by Prescription: 1. Analyses of a Unique Database

Received14 Feb 2003
Accepted24 Sep 2003

Abstract

Objectives: To present sales figures of antifungal drugs for treatment of genital Candida infections in females, which had been purchased in the Swedish county of Skåne (with approximately 1.2 million inhabitants) during the 1990s. To study the relative proportions of the drugs sold by prescription and as over-the-counter (OTC) products.Methods: Sales figures of antifungal drugs for therapy of vulvovaginal candidiasis (VVC) and such recurrent infections (RVVC), for the years 1990–99, were collected from the ‘ACS’ database of the National Corporation of Swedish Pharmacies.Results: The study showed an increase in sales of the type of drugs studied from 45 000 packages in 1990 until mid-93/94, when approximately 70 000 packages were sold (mainly azoles for topical use and fluconazole for oral intake). Thereafter there was a decrease until the end of November 1999, when 54 000 packages were purchased. Of the total sales, 93% were OTC products. Sales of clotrimazole and econazole (for vaginal installation) in 1993–1994 were equal to 85–90 packages/1000 women in the age group 15–45 years. Extremely high sales volumes of fluconazole and itraconazole, for one single year each, could be explained by marketingrelated activities directed to the medical community.Conclusions: As many women with RVVC are not cured by iatrogenic initiatives and women consider themselves able to diagnose episodes of genital Candida infection, affected women generally turn to selfmedication with antifungal OTC products. This stresses the role of pharmacy counseling. Short-term marked alterations in sales volumes may be due to marketing factors rather than changes in the epidemiology of genital Candida infections.

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views127
Downloads1012
Citations

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.